# Target-controlled Infusion of Propofol and Remifentanil for Postoperative Sedation Guided by the Bispectral Index

> **NCT00393003** · PHASE4 · COMPLETED · sponsor: **Hopital Foch** · enrollment: 32 (—)

## Conditions studied

- Postoperative Sedation

## Interventions

- **DEVICE:** Closed-loop anesthesia system

## Key facts

- **NCT ID:** NCT00393003
- **Lead sponsor:** Hopital Foch
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 32 (—)
- **Last updated:** 2009-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00393003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00393003, "Target-controlled Infusion of Propofol and Remifentanil for Postoperative Sedation Guided by the Bispectral Index". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00393003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*